SANOFICONR4,180.00

Sanofi Consumer Healthcare India Limited

· Pharma & Health
₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹9,614 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/12/2024
FY26
31/12/2025
Last 12M
30/06/2026
Inventory Days (DIO)117.18140.58140.58
Receivable Days (DSO)6.9012.3012.30
Payable Days (DPO)201.41180.80211.75
Cash Conversion Cycle (days)-77.33-27.92-58.87
Working Capital Turnover2.772.402.82
Asset Turnover1.681.611.61
Cash Conversion (CFO/Net Income)2.431.161.16
CFO/EBITDA1.620.900.90
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.